High-frequency, at-home monitoring of drug safety and tolerability in clinical trials: Results from studies of fluvoxamine for COVID-19 treatment

Authors

• Eric J Lenze, Washington University School of Medicine in St. Louis
• Madeline Nykamp, Washington University School of Medicine in St. Louis
• J Philip Miller, Washington University School of Medicine in St. Louis
• Angela Stevens, Washington University School of Medicine in St. Louis
• Julia Schweiger, Washington University School of Medicine in St. Louis
• Torie Gettinger, Washington University School of Medicine in St. Louis
• Michael Yingling, Washington University School of Medicine in St. Louis
• Yi Zhang, Washington University School of Medicine in St. Louis
• Ginger E Nicol, Washington University School of Medicine in St. Louis
• Charles F Zorumski, Washington University School of Medicine in St. Louis
• Angela M Reiersen, Washington University School of Medicine in St. Louis

Journal

Clinical and Translational Science

Publication Date

7-1-2025

Volume

18

Issue

7

First Page

e70292

Document Type

Open Access Publication

DOI

10.1111/cts.70292

Rights and Permissions

E. J. Lenze, M. Nykamp, J. P. Miller, et al., “High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment,” Clinical and Translational Science18, no. 7 (2025): e70292, https://doi.org/10.1111/cts.70292. © 2025 The Author(s). Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Recommended Citation

Lenze, Eric J; Nykamp, Madeline; Miller, J Philip; Stevens, Angela; Schweiger, Julia; Gettinger, Torie; Yingling, Michael; Zhang, Yi; Nicol, Ginger E; Zorumski, Charles F; and Reiersen, Angela M, "High-frequency, at-home monitoring of drug safety and tolerability in clinical trials: Results from studies of fluvoxamine for COVID-19 treatment." Clinical and Translational Science. 18, 7. e70292 (2025).
https://digitalcommons.wustl.edu/oa_4/7016

Department

ICTS (Institute of Clinical and Translational Sciences)